Frost & Sullivan Recognizes CyberMDX as the Leader in Medical Devices and Assets Security Technology Innovation

Advertisement

BEGIN ARTICLE PREVIEW:

NEW YORK, Sept. 16, 2020 /PRNewswire/ — CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced that the company has received Frost & Sullivan’s 2020 Technology Innovation Leadership Award as the leader in medical devices and assets security technology innovation in North America. The Technology Innovation Leadership Award recognizes companies that lead the development and successful introduction of high-tech solutions to customers’ most pressing needs.
With increasing digitization of hospitals and a fast growing fleet of connected medical devices around the world, the quality and functionality of healthcare devices are at higher risk from data breaches than ever before. As such, cyber security is becoming an urgent requirement for all healthcare stakeholders to protect their critical medical devices and clinical assets on the Internet of Medical Things (IoMT).
According to the Frost & Sullivan report, “CyberMDX demonstrates thought leadership, technical excellence, and a unique customization ability to strengthen healthcare security through its platform. It also empowers the continuous discovery of medical devices and intelligent micro-segmentation policies and responses during cyberattacks.”
CyberMDX developed its cyber intelligence platform to enable secure connectivity for medical devices and clinical assets. Through the platform’s real-time threat monitoring and prevention capabilities, …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE